FDA Inspection 1221028 — Siegfried USA, LLC

Siegfried USA, LLC — FEI 2227314

The FDA completed an inspection of Siegfried USA, LLC on September 27, 2023 in Pennsville, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pennsville, NJ (United States)